CANHR is resolved to end the misuse of psychoactive drugs in nursing homes. This blog is our primary forum for discussing how to change the pro-drugging culture of most nursing homes, physicians and nursing staff. Please help us by sharing your experiences, newsworthy developments and suggestions here.

About the Authors

Golden Living (Redding) Hit with Drugging Citation

Golden Living Center in Redding was the subject of a Class A citation from the Department of Public Health (DPH) earlier this year that hopefully represents a shift in enforcement of nursing home rules against the irresponsible use of psychotropic … Continue reading

Share

Music That Moves People

Last month, at the Sundance Film Festival, a documentary about an exciting dementia care program, “Alive Inside,” was tabbed for the vaunted Audience Award in documentary films. The film centers on the power of music to stimulate the mind, even … Continue reading

Share

DPH to Hospitals: Psych Drug Reductions Start With You

This week, DPH released an All-Facilities Letter (AFL) #14-05 to hospitals regarding nursing home obligations to verify informed consent for psych drugs before administering them. You may wonder: why would DPH send a letter to hospitals about nursing home responsibilities? … Continue reading

Share

DPH’s Kinda Good New Informed Consent Guidelines

DPH gave nursing home residents a mixed-bag holiday gift regarding informed consent just before the new year. DPH released All-Facilities Letter (AFL) #13-38 and accompanying “Frequently Asked Questions” (FAQ) document regarding informed consent. The new FAQ form revised and added … Continue reading

Share

Study Shows Nursing Homes Lack Antipsychotic Training

A recent study in the Journal of the American Medical Directors Association shows an alarming lack of information about good dementia care, chemical restraints, and non-drug interventions. The study was based on survey information collected from nursing home staff members … Continue reading

Share

$2.2 Billion Johnson & Johnson Settlement Sends New Warning: Antipsychotic Drugs Should Not Be Used to Treat Dementia

In response to the recent $2.2 billion settlement with Johnson and Johnson for mismarketing the antipsychotic drug Risperdal for elderly people with dementia, CANHR and other long term care consumer advocates released the following statement (click here for a pdf … Continue reading

Share

Psychiatrists Against Drugging for Dementia

In a remarkable turn, the American Psychiatric Association recently¬†advised physicians and patients to question five common antipsychotic prescribing practices. Four of the five warnings from the APA related to the use of antipsychotics for “treating” dementia: 1) Don’t use antipsychotics … Continue reading

Share

CANHR to co-host Modesto Dementia Care Symposium

CANHR will be co-hosting its eighth dementia care symposium on November 12, 2013. This time, CANHR is bringing its comfort-focused care road show to the Modesto area for a FREE half-day event featuring presentations from dementia care experts and a … Continue reading

Share

The Tale of Two Parkviews: Slack DPH Enforcement is Business as Usual

by Michael Connors and Anthony Chicotel, CANHR Advocacy Staff Can the Department of Public Health (DPH) try any harder to send the message that nothing really has changed about its tolerance for the rampant chemical restraint of nursing home residents? … Continue reading

Share

Counting the Unnecessary Deaths

by Anthony Chicotel, CANHR Staff Attorney While listening to various presentations that decry the misuse of antipsychotic drugs, I often hear a statement to the effect of “studies show that for every 100 elderly dementia care patients treated with antipsychotic … Continue reading

Share